Roche (OTCQX:RHHBY) (OTCQX:RHHBF) will finalize the acquisition of Poseida Therapeutics (NASDAQ:PSTX), a biopharmaceutical ...
Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.
Roche on Wednesday said it planned to complete its purchase of U.S. biopharmaceutical company Poseida Therapeutics , a ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Roche’s wholly owned subsidiary Blue Giant Acquisition Corp. has ...
Roche's strategic changes in drug development and M&A activity may drive future growth, despite recent setbacks in clinical ...
(Alliance News) - Roche Holding AG on Wednesday said that it has completed the tender offer for all outstanding shares of Poseida Therapeutics Inc, a clinical-stage biopharmaceutical company, through ...
Recent health news includes Donald Trump's consideration of an executive order on gas stoves, Roche's acquisition of Poseida, ...
Poseida Therapeutics Inc (PSTX) stock saw a modest uptick, ending the day at $9.56 which represents a slight increase of $0.04 or 0.42% from the prior close of $9.52. The stock opened at $9.52 and ...
Poseida Therapeutics Inc (PSTX) stock saw a decline, ending the day at $9.4 which represents a decrease of $-0.20 or -2.08% from the prior close of $9.6. The stock opened at $9.54 and touched a low of ...
Shares of Poseida Therapeutics, Inc. (NASDAQ:PSTX – Get Free Report) hit a new 52-week high on Tuesday . The stock traded as ...
Poseida Therapeutics, Inc. (NASDAQ:PSTX), a biotechnology company ... with Astellas providing $50 million and Roche (LON:0QQ6) contributing $15 million. These infusions brought Poseida's pro forma ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Roche's wholly owned subsidiary Blue Giant Acquisition Corp. has accepted for payment all shares validly tendered and not ...